Lactose (India) has entered into agreement on August 16, 2019 for availing term loan/ line of credit facility of Rs 39.50 crore from Aditya Birla Finance. Of the total, the term loan will be Rs 37.91 crore. Besides, the company will avail Line of Credit facility of Rs 1.59 crore for meeting regular working capital requirements.
Lactose (India) is a leader and pioneer in the manufacturing of Lactose Monohydrate IP/BP/USP Grades not only in India but in the Whole of Asia.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1694.50 |
| Dr. Reddys Lab | 1223.50 |
| Cipla | 1240.45 |
| Zydus Lifesciences | 944.60 |
| Lupin | 2334.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: